youtube_live
Q2 2027 earnings • 6:00 AM tomorrow
See detailschevron_right
4502:TYO
Takeda Pharmaceutical Co Ltd
¥6,307.00
arrow_downward
-1.56%(-100.00) 1D
Oct 28, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4502...
Open
¥6,395
High
¥6,412
Low
¥6,298
Mkt. cap
10.11T
Avg. vol.
4.50M
Volume
3.93M
Dividend
3.17%
Quarterly dividend
¥50
Ex-dividend date
Sep 29, 2026
52-wk high
¥6,500
52-wk low
¥4,102
EPS
-¥103
Shares outstanding
784.48M
No. of employees
47K
Open
¥6,395
High
¥6,412
Low
¥6,298
Mkt. cap
10.11T
Avg. vol.
4.50M
Volume
3.93M
Dividend
3.17%
Quarterly dividend
¥50
Ex-dividend date
Sep 29, 2026
52-wk high
¥6,500
52-wk low
¥4,102
EPS
-¥103
Shares outstanding
784.48M
No. of employees
47K
News stories
From web sources and news partners
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com